Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic calcium phosphate crystals: pathways to joint degeneration.

Eamonn S Molloy1, Geraldine M McCarthy

  • 1Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. eamonn.molloy@ireland.com

Current Opinion in Rheumatology
|February 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Annals of the rheumatic diseases·2026
Same author

The OMERACT core domain sets for calcium pyrophosphate deposition disease.

Seminars in arthritis and rheumatism·2026
Same author

Rapid access microscopy and real-time case discussion via a secure messaging app improves diagnostic accuracy and management of acute hot swollen joints.

BMJ open quality·2025
Same author

Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus.

Seminars in arthritis and rheumatism·2025
Same author

Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus.

Seminars in arthritis and rheumatism·2025
Same author

A Novel Polarized Light Microscope for the Examination of Birefringent Crystals in Synovial Fluid.

Gout, urate, and crystal deposition disease·2025
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Basic calcium phosphate crystals trigger inflammatory responses by increasing prostaglandin E2 and IL-1beta. Understanding these mechanisms is key to developing therapies for crystal-associated rheumatic diseases.

Area of Science:

  • Rheumatology
  • Molecular Biology
  • Immunology

Background:

  • Basic calcium phosphate (BCP) crystals are linked to rheumatic diseases.
  • The molecular mechanisms behind BCP crystal pathology are not fully understood.

Purpose of the Study:

  • To review recent findings on the molecular mechanisms of BCP crystal-induced inflammation.
  • To elucidate the pathways involved in BCP crystal-associated pathology.

Main Methods:

  • Analysis of studies investigating BCP crystal effects on human fibroblasts and chondrocytes.
  • Examination of inflammatory mediator production (prostaglandin E2, IL-1beta, nitric oxide, matrix metalloproteinases).
  • Investigation of signaling pathways including protein kinase C and extracellular-regulated kinase.

Related Experiment Videos

Main Results:

  • BCP crystals induce prostaglandin E2 production via cyclooxygenases 1 and 2 in fibroblasts.
  • BCP crystals upregulate IL-1beta in fibroblasts and chondrocytes.
  • Octacalcium phosphate crystals increase nitric oxide production in chondrocytes.
  • Protein kinase C isoforms mediate BCP crystal-induced matrix metalloproteinase expression through distinct pathways.
  • BCP crystals activate the transcription factor Egr-1, potentially contributing to fibroblast proliferation.

Conclusions:

  • Recent research highlights BCP crystals' role in stimulating inflammatory mediators like prostaglandin E2, nitric oxide, IL-1beta, and matrix metalloproteinases.
  • Elucidation of these mechanisms is crucial for developing effective treatments for BCP crystal-associated diseases.